SCHEMBL6958711

SCHEMBL6958711

O=C(O)C(Sc1cccc(Cl)c1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TERT O14746 1/20 0.40
KIF11 P52732 1/20 0.40
PARP1 P09874 1/20 0.40
SLC6A9 P48067 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TRPM5 Q9NZQ8 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TYMP P19971 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
GRM5 P41594 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4421523 0.84 CYP2C9 (0.42) CYP2C9CYP2C19HSD17B10TERTKIF11
SCHEMBL1814201 0.78 FOLH1 (0.45) CYP2C9CYP2C19HSD17B10KIF11PARP1
SCHEMBL6960077 0.78 KIF11 (0.40) HSD17B10TERTKIF11PARP1MEN1
SCHEMBL6965136 0.78 LMNA (0.46) CYP2C9CYP2C19HSD17B10MAPTLMNA
SCHEMBL7369925 0.77 ALOX12 (0.44) MAPTHTTNPC1TRPM5ALDH1A1
SCHEMBL934324 0.75 EPHX1 (0.51) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL6956928 0.74 CES2 (0.47) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL12125560 0.72 GRM5 (0.49) CYP2C9CYP2C19MEN1KMT2ALMNA
SCHEMBL6959322 0.72 EPHX1 (0.57) KIF11MEN1KMT2AMAPTNPC1
SCHEMBL4540229 0.72 LMNA (0.54) MEN1KMT2AMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed